SCHEMBL22062337

SCHEMBL22062337

CC1=NN(C)C(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17341934 0.70 GAA (0.30) —
SCHEMBL20285395 0.69 — —
SCHEMBL21394579 0.57 PDE4D (0.50) —
SCHEMBL13160601 0.55 — —
SCHEMBL10516967 0.54 — —
SCHEMBL25080563 0.53 — —
SCHEMBL8278874 0.53 — —
SCHEMBL21827213 0.51 — —
SCHEMBL7339849 0.51 — —
SCHEMBL8405826 0.51 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303546-A1 Process And Intermediates For The Preparation Of Pyroxasulfone ADAMA AGAN LTD. (IL) 2023-09-28 — — US disclosed
US-10676480-B2 Anti-cancer compounds targeting Ral GTPases and methods of using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2020-06-09 — — US disclosed
Send feedback